About
Celleo Biotech is a biotechnology company founded in early 2022 and headquartered in Melbourne, Australia. The company specializes in developing intelligent production systems for the manufacture of Cell & Gene Therapies, aiming to bridge the production gap for advanced therapeutics. With a focus on scaling these therapies for broader patient access, Celleo combines deep biological expertise with modern manufacturing techniques. Celleo's flagship product is the Larkem™ V40 system, designed for the commercial-scale manufacture of CAR-T cell therapies. The company collaborates with leading biotherapeutics firms and Contract Development and Manufacturing Organizations (CDMOs) to enhance the production of advanced therapies. Their state-of-the-art facilities include OGTR-certified laboratories, enabling work with advanced biologicals critical for technology development. Celleo is committed to transforming cell therapy manufacturing to achieve significant health outcomes on a population level.
Technologies
Keywords
Company Information
-
Employees 22
-
Founded 2022
Location
655 Elizabeth St, Melbourne, Victoria, Australia, 3000
